|
CN105349545A
|
|
NT-proBNP nucleic acid aptamer and application thereof
|
|
CN105274250A
|
|
Marker used for detecting glioblastoma disease development
|
|
CN105316286A
|
|
Method for preparing recombination mesenchymal stem cell and recombination mesenchymal stem cell prepared through method
|
|
CN105296431A
|
|
Tumor binding specific gamma delta TCR gene modified alpha beta T cell and cancer suppression application thereof
|
|
CN105343894A
|
|
Recombinant mesenchymal stem cell efficient in secreting prostaglandin E2 (PGE2) and its application
|
|
CN105232474A
|
|
Simple method for preparing PLGA microspheres with uniform particle size
|
|
CN105349696A
|
|
JEV (Japanese type B encephalitis virus) nucleic acid assay kit and application thereof
|
|
CN105125537A
|
|
Application of 5-(4-hydroxide radical-3-methylbenzylidene) rhodanine to preparation of medicine preventing or treating cranial nerve tissue damage
|
|
CN105085656A
|
|
P19/Ebi3 compound and application of polyclonal antibody of P19/Ebi3 compound in SLE (systemic lupus erythematosus) diagnosis and treatment
|
|
CN105087467A
|
|
Preparation method of kidney sertoli cells and special mediums thereof
|
|
CN105062976A
|
|
Pulmonary artery hypertension treatment drug stem cell screening model and application thereof
|
|
CN105130978A
|
|
Compound and application thereof in the aspect of Parkinson's disease
|
|
CN104961803A
|
|
Polypeptide drug for treating myocardial ischemia reperfusion injury
|
|
CN104961804A
|
|
P38 alpha antagonistic peptide mutant and application thereof
|
|
CN105031629A
|
|
SAK-HV oral controlled-release microsphere, and preparation method and application thereof
|
|
CN105039320A
|
|
RNA, application thereof, composition containing same, recombinant expression vector, and host cell
|
|
CN105176998A
|
|
RNA and use thereof, composition containing the same, recombinant expression vector and host cell
|
|
CN105112446A
|
|
Method for high-efficiency establishment of genetically modified animal model through haploid stem cells
|
|
CN105031611A
|
|
Application of netrin-1 protein in preparing drug for treating tumor
|
|
CN104940953A
|
|
Immunogene therapeutic drug for chronic hepatitis B and preparation method for immunogene therapeutic drug
|
